Spanish biotech firm Oncomatryx has secured €12.5 million in EU funding to launch a new clinical trial of a promising cancer treatment.
The trea
Already registered? Log in
This article is free for you...
We're glad you're enjoying the Spanish Eye. Register a
free account to read this article, comment on stories and receive newsletters straight to your inbox.
Or subscribe now for unlimited access
By submitting your email address you agree for The Spanish Eye to send you communication by email